Clinical Trial Protocol for Porcine Islet Xenotransplantation in South Korea
- Author:
Byung-Joon KIM
1
;
Jun-Seop SHIN
;
Byoung-Hoon MIN
;
Jong-Min KIM
;
Chung-Gyu PARK
;
Hee-Jung KANG
;
Eung Soo HWANG
;
Won-Woo LEE
;
Jung-Sik KIM
;
Hyun Je KIM
;
Iov KWON
;
Jae Sung KIM
;
Geun Soo KIM
;
Joonho MOON
;
Du Yeon SHIN
;
Bumrae CHO
;
Heung-Mo YANG
;
Sung Joo KIM
;
Kwang-Won KIM
Author Information
- Publication Type:Original Article
- From:Diabetes & Metabolism Journal 2024;48(6):1160-1168
- CountryRepublic of Korea
- Language:English
-
Abstract:
Background:Islet transplantation holds promise for treating selected type 1 diabetes mellitus patients, yet the scarcity of human donor organs impedes widespread adoption. Porcine islets, deemed a viable alternative, recently demonstrated successful longterm survival without zoonotic risks in a clinically relevant pig-to-non-human primate islet transplantation model. This success prompted the development of a clinical trial protocol for porcine islet xenotransplantation in humans.
Methods:A single-center, open-label clinical trial initiated by the sponsor will assess the safety and efficacy of porcine islet transplantation for diabetes patients at Gachon Hospital. The protocol received approval from the Gachon Hospital Institutional Review Board (IRB) and the Korean Ministry of Food and Drug Safety (MFDS) under the Investigational New Drug (IND) process. Two diabetic patients, experiencing inadequate glycemic control despite intensive insulin treatment and frequent hypoglycemic unawareness, will be enrolled. Participants and their family members will engage in deliberation before xenotransplantation during the screening period. Each patient will receive islets isolated from designated pathogen-free pigs. Immunosuppressants and systemic infection prophylaxis will follow the program schedule. The primary endpoint is to confirm the safety of porcine islets in patients, and the secondary endpoint is to assess whether porcine islets can reduce insulin dose and the frequency of hypoglycemic unawareness.
Conclusion:A clinical trial protocol adhering to global consensus guidelines for porcine islet xenotransplantation is presented, facilitating streamlined implementation of comparable human trials worldwide.
